Hovione Farmaciencia SA 2020 SR
The report details Hovione's sustainability performance for fiscal years 2019 and 2020, emphasizing its commitment to the UN Sustainable Development Goals and its B Corp certification. Key highlights include a 21% reduction in greenhouse gas emissions from the 2016 baseline and the implementation of 'Project Spring' to scale up Captisol production for COVID-19 treatments. The company achieved a 53% renewable energy share and a 55% circular material use rate in 2020. It also focuses on diversity, reporting 29% female representation on its board and 25% in enterprise leadership, and maintains a strong focus on occupational health and safety with zero fatalities.
Company: Hovione Farmaciencia SA
Sector: Manufacturing
Country: Portugal
Year: 2020
Type: SR
Pages: 86
Hovione Farmaciencia SA
The report details Hovione's sustainability performance for fiscal years 2019 and 2020, emphasizing its commitment to the UN Sustainable Development Goals and its B Corp certification. Key highlights include a 21% reduction in greenhouse gas emissions from the 2016 baseline and the implementation of 'Project Spring' to scale up Captisol production for COVID-19 treatments. The company achieved a 53% renewable energy share and a 55% circular material use rate in 2020. It also focuses on diversity, reporting 29% female representation on its board and 25% in enterprise leadership, and maintains a strong focus on occupational health and safety with zero fatalities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 1, 2019 - Mar 31, 2021
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees